Literature DB >> 24435929

Potential effects of molecular testing of indeterminate thyroid nodule fine needle aspiration biopsy on thyroidectomy volume.

Priya H Dedhia1, Gustavo A Rubio, Mark S Cohen, Barbra S Miller, Paul G Gauger, David T Hughes.   

Abstract

BACKGROUND: Increasing utilization of genetic expression profiling (GEP) for thyroid nodules with indeterminate fine needle aspiration (FNA) results will potentially decrease the number of patients requiring diagnostic thyroidectomy. This study sought to determine the potential effects of GEP for indeterminate thyroid FNA results on thyroidectomy volume.
METHODS: A retrospective review of thyroidectomy procedures performed over 1 year at the University of Michigan in the endocrine surgery division evaluated the indications for thyroidectomy, FNA Bethesda classification, and final surgical pathology to determine how application of GEP on indeterminate FNA results would affect decision for surgery and subsequent thyroidectomy volume.
RESULTS: During the study period, 358 thyroidectomies were performed. The indication for procedure included: FNA findings, n = 122; symptomatic multinodular goiter, n = 85; nodule >4 cm, n = 30; Graves', n = 26; other, n = 95. FNA was performed in 231 patients. Bethesda classification included: benign, n = 69; malignant, n = 55; follicular lesion of undetermined significance, n = 59; follicular neoplasm, n = 20; suspicious for malignancy, n = 16; nondiagnostic, n = 12. If standard GEP was performed for all indeterminate FNA results, it would have influenced the decision for surgery in 68 (19 %) patients. Assuming 38 % of indeterminate FNA specimens will have benign results on genetic profiling, 27 patients would not have undergone thyroidectomy, translating into a 7.2 % decrease in overall thyroidectomy volume over a year.
CONCLUSIONS: In an academic endocrine surgery program, the most common indication for thyroidectomy is an FNA result; however, standard application of GEP for all indeterminate thyroid FNAs would result in a minimal reduction in overall thyroidectomy volume.

Entities:  

Mesh:

Year:  2014        PMID: 24435929     DOI: 10.1007/s00268-013-2430-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

1.  Molecular classification of thyroid nodules using high-dimensionality genomic data.

Authors:  Darya Chudova; Jonathan I Wilde; Eric T Wang; Hui Wang; Nusrat Rabbee; Camila M Egidio; Jessica Reynolds; Ed Tom; Moraima Pagan; C Ted Rigl; Lyssa Friedman; C Charles Wang; Richard B Lanman; Martha Zeiger; Electron Kebebew; Juan Rosai; Giovanni Fellegara; Virginia A LiVolsi; Giulia C Kennedy
Journal:  J Clin Endocrinol Metab       Date:  2010-09-08       Impact factor: 5.958

Review 2.  The Bethesda System For Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Am J Clin Pathol       Date:  2009-11       Impact factor: 2.493

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

Authors:  Erik K Alexander; Giulia C Kennedy; Zubair W Baloch; Edmund S Cibas; Darya Chudova; James Diggans; Lyssa Friedman; Richard T Kloos; Virginia A LiVolsi; Susan J Mandel; Stephen S Raab; Juan Rosai; David L Steward; P Sean Walsh; Jonathan I Wilde; Martha A Zeiger; Richard B Lanman; Bryan R Haugen
Journal:  N Engl J Med       Date:  2012-06-25       Impact factor: 91.245

5.  The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.

Authors:  Daniel S Duick; Joshua P Klopper; James C Diggans; Lyssa Friedman; Giulia C Kennedy; Richard B Lanman; Bryan McIver
Journal:  Thyroid       Date:  2012-08-08       Impact factor: 6.568

6.  Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation.

Authors:  Leila Yassa; Edmund S Cibas; Carol B Benson; Mary C Frates; Peter M Doubilet; Atul A Gawande; Francis D Moore; Brian W Kim; Vânia Nosé; Ellen Marqusee; P Reed Larsen; Erik K Alexander
Journal:  Cancer       Date:  2007-12-25       Impact factor: 6.860

7.  Information for clinicians: commercially available molecular diagnosis testing in the evaluation of thyroid nodule fine-needle aspiration specimens.

Authors:  Steven P Hodak; David S Rosenthal
Journal:  Thyroid       Date:  2012-11-27       Impact factor: 6.568

  7 in total
  5 in total

Review 1.  Thyroid follicular microcarcinoma.

Authors:  Andrea Casaril; Marco Inama; Harmony Impellizzeri; Matilde Bacchion; Mihail Creciun; Gianluigi Moretto
Journal:  Gland Surg       Date:  2020-01

Review 2.  American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making.

Authors:  Robert L Ferris; Zubair Baloch; Victor Bernet; Amy Chen; Thomas J Fahey; Ian Ganly; Steven P Hodak; Electron Kebebew; Kepal N Patel; Ashok Shaha; David L Steward; Ralph P Tufano; Sam M Wiseman; Sally E Carty
Journal:  Thyroid       Date:  2015-06-24       Impact factor: 6.568

3.  Percutaneous CT-guided needle biopsies of musculoskeletal tumors: a 5-year analysis of non-diagnostic biopsies.

Authors:  Connie Y Chang; Ambrose J Huang; Miriam A Bredella; Martin Torriani; Elkan F Halpern; Daniel I Rosenthal; Dempsey S Springfield
Journal:  Skeletal Radiol       Date:  2015-09-04       Impact factor: 2.199

Review 4.  The Role of Molecular Testing for the Indeterminate Thyroid FNA.

Authors:  Esther Diana Rossi; Liron Pantanowitz; William C Faquin
Journal:  Genes (Basel)       Date:  2019-09-23       Impact factor: 4.096

Review 5.  Preoperative Molecular Markers in Thyroid Nodules.

Authors:  Zeyad T Sahli; Philip W Smith; Christopher B Umbricht; Martha A Zeiger
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.